Improvement of itch and pain in patients with prurigo nodularis treated with serlopitant: Secondary analysis of phase 2 clinical trial

Background: This analysis reports baseline characteristics of patients with prurigo nodularis (PN) enrolled in a study of serlopitant (NCT02196324), one of the largest randomized controlled trials conducted to date in this patient population, and assesses the impact of treatment on sensory qualities of PN.
Source: Journal of the American Academy of Dermatology - Category: Dermatology Source Type: research